Rallybio Corporation (RLYB) NASDAQ
16.23
-0.64(-3.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
16.23
-0.64(-3.79%)
Currency In USD
| Market Cap | 30.91M |
| Enterprise Value | -292,759 |
| P/E Ratio | -11.81 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 100.22 |
| Price/Book Ratio | 1.84 |
| Enterprise/Revenue | 52.27 |
| Enterprise/EBITDA | -1.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -9.11 |
| Operating Margin | -32.78 |
| Return On Assets | -0.14 |
| Return On Equity | -0.14 |
| Revenue | 858,000 |
| Revenue/Share | 0.15 |
| Gross Profit | 766,000 |
| EBITDA | -27.97M |
| Net Income | -8.98M |
| Diluted EPS | -1.59 |
| Total Cash | 46.8M |
| Total Cash/Share | 8.23 |
| Total Debt | 154,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 12.92 |
| Book Value Per Share | 8.84 |
| 52-Week Change | 608.73 |
| 52-Week High | 17.57 |
| 52-Week Low | 2.16 |
| Moving Average 50 Days | 10.95 |
| Moving Average 200 Days | 6.89 |
| Average Volume | 276,330 |
| Shares Outstanding | 5.3M |
| % Held by Institutions | 82.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | February 06, 2026 |